CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-26 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise | +5,617 | 150,690 | ||
| 2025-02-26 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −2,494 | $34.80 | $87K | 148,196 |
| 2025-02-26 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise · Restricted Stock Unit Award | −5,617 | 16,854 | ||
| 2025-02-25 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Sale 10b5-1 | −3,743 | $35.26 | $132K | 7,717 |
| 2025-02-23 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +7,689 | 203,852 | ||
| 2025-02-23 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −3,414 | $35.32 | $121K | 200,438 |
| 2025-02-23 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −7,689 | 15,379 | ||
| 2025-02-23 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +8,738 | 200,621 | ||
| 2025-02-23 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −3,880 | $35.32 | $137K | 196,741 |
| 2025-02-23 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −8,738 | 17,476 | ||
| 2025-02-23 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise 10b5-1 | +2,284 | 12,132 | ||
| 2025-02-23 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Shares withheld for taxes 10b5-1 | −672 | $35.32 | $24K | 11,460 |
| 2025-02-23 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise · Restricted Stock Unit Award 10b5-1 | −2,284 | 4,567 | ||
| 2025-02-23 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise | +5,825 | 147,660 | ||
| 2025-02-23 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −2,587 | $35.32 | $91K | 145,073 |
| 2025-02-23 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise · Restricted Stock Unit Award | −5,825 | 11,650 | ||
| 2025-02-23 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +6,408 | 92,714 | ||
| 2025-02-23 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −2,846 | $35.32 | $101K | 89,868 |
| 2025-02-23 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −6,408 | 12,815 | ||
| 2025-02-23 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +7,689 | 77,337 |
Page 15 of 41 · 804 trades